N-methyl glucamine antimoniate or Glucantime
Rapp, C.; Simon, F.; Dordain, M.L.
Medecine Tropicale Revue du Corps de Sante Colonial 60(4): 342-343
2000
ISSN/ISBN: 0025-682X PMID: 11436584 Document Number: 520318
Document emailed within 1 workday
Related Documents
Layegh, P.; Yazdanpanah, M.Javad.; Vosugh, E.Mohammadi.; Pezeshkpoor, F.; Shakeri, M.Taghi.; Moghiman, T. 2007: Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis American Journal of Tropical Medicine and Hygiene 77(1): 99-101Lewandrowski, K.; Lee-Lewandrowski, E.; Bowers, G.N.; McComb, R.B. 1992: Investigation of N-methyl-D-glucamine buffer for assay of alkaline phosphatase in serum Clinical Chemistry 38(11): 2286-2294
Romanovich, A.I.; Chizhov, O.S.; Sviridov, A.F. 1988: Synthetic studies in the series of polyene macrolide antibiotics. 5. Synthesis of methyl-2,4,6-trideoxy-2,4-di-C-methyl-alpha-L- gluco-hexopyranoside and methyl-2,4,6-trideoxy-2,4-di-C-methyl- alpha-L-manno-hexopyranoside, the stereoisomers of the C33-C38 fragment of amphotericin B Bioorganicheskaia Khimiia 14(8): 1109-1112
Rapp, C.; Imbert, P.; Darie, H.; Simon, F.; Gros, P.; Debord, T.; Roué, R. 2003: Liposomal amphotericin B treatment of cutaneous leishmaniasis contracted in Djibouti and resistant to meglumine antimoniate Bulletin de la Societe de Pathologie Exotique 96(3): 209-211
Ceyhan, M.; Kinik, E.; Diker, S.; Yurdakök, M.; Dilmen, U. 1984: The hyperglycemic effect of N-methylglucamine antimonate (glucantime) Mikrobiyoloji Bulteni 18(4): 185-189
Ramos García, A.N.; Pérez Avila, J.; Pérez Ramos, E.; Díaz Hernández, A.; Ruiz Pérez, A. 1984: Treatment of cutaneous leishmaniasis with glucantime. Apropos of 9 cases Revista Cubana de Medicina Tropical 36(2): 151-159
Darabi, H.; Abolhassani, M.; Kariminia, A.; Alimohammadian, M.H. 2002: Expansion of gammadelta T Cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 6(5): 258-262
Solano, E.; Hidalgo, H.; Zeledón, R. 1984: Successful intralesional treatment of leishmaniasis caused by Leishmania brasiliensis panamensis using glucantime Medicina Cutanea Ibero-Latino-Americana 12(1): 19-24
Zhang, S.R.; Xu, R.M.; Jin, B.Y.; Wu, Y.L.; Han, C. 1996: Protection of dl-(15R)-15 methyl-PGE2 methyl ester (PG6E) on experimental ulcers in rats Yao Xue Xue Bao 31(10): 746-750
Meng, X.Y.; Zhang, X.P.; Chen, X.H.; Yu, A.Z. 1991: Synthesis and antibacterial as well as antineoplastic activities of 2,4-diamino-5-methyl-6-(N-methyl-substituted benzyl) aminoquinazolines Yao Xue Xue Bao 26(5): 383-386
Colasanti, B.K.; Trotter, R.R. 1977: Enhanced ocular penetration of the methyl ester of (+/-) alpha-methyl-para-tyrosine after lontophoresis Archives Internationales de Pharmacodynamie et de Therapie 228(1): 171-176
De Amici, M.; De Micheli, C.; Grana, E.; Lucchelli, A.; Zonta, F. 1990: Nitrile oxides in medicinal chemistry. 3. Synthesis and bioenantioselectivity of (+)- and (-)-2-methyl-5-[(dimethylamino)-methyl]-3-oxo-isoxazolidine methiodide Farmaco 45(7-8): 859-866
Zalewska, A.; Winnicka, M.M.; Wiśniewski, K. 1996: Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4) Polish Journal of Pharmacology 48(4): 415-423
Mineura, K.; Mori, T.; Katakura, R.; Sasaki, T. 1981: Therapeutic effects of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and radiation on the rat glioma No Shinkei Geka. Neurological Surgery 9(3): 257-265
Tauscher, M.; Eckhardt, G.; Geisel, B.; Schroeder, G. 1977: Isolation and structure determination of the metabolites of 2-(1,3-dimethyl-xanthinyl-(7)-methyl)-4-methyl-morpholine--a xantinol derivative--from rat urine Arzneimittel-Forschung 27(12): 2344-2347
Blickens, D.A.; Riggi, S.J. 1971: Carbohydrate metabolism in normal and hyperglycemic animals treated with 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride and phenformin Journal of Pharmacology and Experimental Therapeutics 177(3): 536-545
Fukuda, K.; Shindo, H.; Shimizu, F.; Arakawa, M.; Mizuhira, V. 1980: Ultrastructral changes induced by 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea in L1210 lymphocytic leukemia cells in mice Cancer Research 40(1): 133-138
Shimizu, K.; Ushio, Y.; Hayakawa, T.; Mogami, H. 1980: Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats Cancer Research 40(4): 1341-1343
Galegov, G.A.; Vladyko, A.S.; Linitskaia, G.L.; Shobukhov, V.M. 1981: Effect of amantadine (1-aminoadamantane) and remantadine (alpha-methyl-1-adamantane methyl amine) hydrochlorides on formation of influenza a viral proteins Voprosy Meditsinskoi Khimii 27(2): 251-254
Sladowska, H.; Zawisza, T. 1986: Synthesis and properties of amides of 1-benzyl-3-methyl- and 1-butyl-3-phenyl-7-methyl-4-oxo-2-thioxo (2,4-dioxo)-1,2,3,4-tetrahydropyrido-[2,3-d]pyrimidine-6-carboxy lic acids Il Farmaco; Edizione Scientifica 41(12): 954-963